Top 11 ankylosing spondylitis new treatment 2020 in 2022

Below are the best information and knowledge on the subject ankylosing spondylitis new treatment 2020 compiled and compiled by our own team alltopus:

1. U.S. FDA Approves Pfizer’s XELJANZ® (tofacitinib) for the Treatment of Active Ankylosing Spondylitis | Pfizer

Author: www.pfizer.com

Date Submitted: 10/05/2021 02:28 PM

Average star voting: 3 ⭐ ( 80370 reviews)

Summary: Pfizer Inc. (NYSE: PFE) announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental New Drug Application (sNDA) for XELJANZ ® / XELJANZ ® XR (tofacitinib) for the treatment of adults with active ankylosing spondylitis (AS) who have had an inadequate response or intolerance to one or more tumor necrosis factor (TNF) blockers. “We are proud to offer XELJANZ, a treatment option for ankylosing spondylitis that does not require an injection or an infusion, to treat this debilitating and chronic immuno-inflammatory disease,” said Mike Gladstone, Global President, Inflammation & Immunology, Pfizer. “This regulatory approval affirms the clinical value and versatility of XELJANZ, the first and only Janus kinase (JAK) inhibitor approved for five indications in the United States for the treatment of patients with certain immuno-inflammatory conditions.” The approval of XELJANZ for AS is based on data from a Phase 3, multicenter, randomized, double-blind,

Match with the search results: for the treatment of adults with active ankylosing spondylitis (AS) who have had an inadequate response or intolerance to one or more tumor ……. read more

U.S. FDA Approves Pfizer’s XELJANZ® (tofacitinib) for the Treatment of Active Ankylosing Spondylitis | Pfizer

2. New Drugs for Ankylosing Spondylitis Treatment Coming Down the Pipeline: An Updated Clinical Status by DelveInsight

Author: www.webmd.com

Date Submitted: 12/08/2019 02:00 PM

Average star voting: 5 ⭐ ( 78434 reviews)

Summary: Around 30+ notable companies are developing Ankylosing Spondylitis therapies. There are currently many new or repurposed drugs in clinical trials being…

Match with the search results: But in the last several years, the FDA approved two new injectable drugs: ixekizumab (Taltz) and secukinumab (Cosentyx). They both block another ……. read more

New Drugs for Ankylosing Spondylitis Treatment Coming Down the Pipeline: An Updated Clinical Status by DelveInsight

3. JAK Inhibitors Offer New Hope for Treating Ankylosing Spondylitis

Author: www.globenewswire.com

Date Submitted: 08/13/2019 01:16 PM

Average star voting: 5 ⭐ ( 60411 reviews)

Summary: People with ankylosing spondylitis responded well to a treatment previously used for rheumatoid arthritis, according to a 2020 study. Will this drug, part of a class called JAK inhibitors, become the new norm?

Match with the search results: Tofacitinib, sold under the brand Xeljanz, is a medication used to treat Rheumatoid Arthritis, Psoriatic Arthritis, and Ulcerative Colitis….. read more

JAK Inhibitors Offer New Hope for Treating Ankylosing Spondylitis

4. IL-17 inhibitors offer promising ‘effective’ treatment for ankylosing spondylitis

Author: www.spineuniverse.com

Date Submitted: 04/28/2019 02:07 PM

Average star voting: 3 ⭐ ( 20708 reviews)

Summary: IL-17 inhibitors have recently demonstrated “quite effective” results in treating ankylosing spondylitis, according to a speaker at the 2020 Congress of Clinical Rheumatology-East.
“NSAIDs work in about 50% of patients, TNF inhibitors is very good, and IL-17 is going to be quite effective,” said Daniel E. Furst, MD, of the University of Washington, in Seattle, and UCLA,

Match with the search results: People with ankylosing spondylitis responded well to a treatment previously used for rheumatoid arthritis, according to a 2020 study….. read more

IL-17 inhibitors offer promising 'effective' treatment for ankylosing spondylitis

5. New medication on the horizon for ankylosing spondylitis | National Axial Spondyloarthritis Society

Author: academic.oup.com

Date Submitted: 06/18/2021 11:47 PM

Average star voting: 5 ⭐ ( 59911 reviews)

Summary: A new medication called upadacitinib has been approved in the European Union as a treatment for active ankylosing spondylitis (AS) in adults.

Match with the search results: et al. EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update . Ann Rheum Dis. 2020. ;. 79….. read more

New medication on the horizon for ankylosing spondylitis | National Axial Spondyloarthritis Society

6. Can Ankylosing Spondylitis Be Cured? An Expert Weighs In

Author: www.healio.com

Date Submitted: 01/17/2020 09:17 AM

Average star voting: 5 ⭐ ( 81876 reviews)

Summary: Ankylosing spondylitis is a disease that affects the spine. Read on to learn an expert’s thoughts on the disease and how it’s treated.

Match with the search results: IL-17 inhibitors have recently demonstrated “quite effective” results in treating ankylosing spondylitis, according to a speaker at the 2020 ……. read more

Can Ankylosing Spondylitis Be Cured? An Expert Weighs In

7. New developments in our understanding of ankylosing spondylitis pathogenesis

Author: nass.co.uk

Date Submitted: 04/23/2021 10:49 PM

Average star voting: 4 ⭐ ( 74854 reviews)

Summary:

Match with the search results: A new medication called upadacitinib has been approved in the European Union as a treatment for active ankylosing spondylitis (AS) in adults….. read more

New developments in our understanding of ankylosing spondylitis pathogenesis

8. New Treatment Approved for Ankylosing Spondylitis: FDA OKs First JAK Inhibitor, Tofacitinib – SAA

Author: www.nhs.uk

Date Submitted: 10/30/2021 08:28 AM

Average star voting: 4 ⭐ ( 31296 reviews)

Summary:

Match with the search results: Monoclonal antibodies, such as secukinumab and ixekizumab, may be offered to people with AS who do not respond to NSAIDs or anti-TNF medicine. This type of ……. read more

New Treatment Approved for Ankylosing Spondylitis: FDA OKs First JAK Inhibitor, Tofacitinib - SAA

9. New treatment options in ankylosing spondylitis: a role for anti-TNFα therapy

Author: www.healthline.com

Date Submitted: 07/28/2019 09:14 PM

Average star voting: 4 ⭐ ( 28834 reviews)

Summary:

Match with the search results: What are the newest treatments for ankylosing spondylitis? · ustekinumab (Stelara), an IL12/23 inhibitor · tofacitinib (Xeljanz), a JAK inhibitor ……. read more

New treatment options in ankylosing spondylitis: a role for anti-TNFα therapy

10. Drug treatment of ankylosing spondylitis and related complications: an overlook review

Author: ard.bmj.com

Date Submitted: 04/11/2020 07:22 AM

Average star voting: 4 ⭐ ( 91155 reviews)

Summary: Drug treatment of ankylosing spondylitis and related complications: an overlook review

Match with the search results: If approved by regulatory agencies, tofacitinib could be one of a new class of drugs for use in ankylosing spondylitis, adding to the currently limited ……. read more

Drug treatment of ankylosing spondylitis and related complications: an overlook review

11. 2022 Ankylosing Spondylitis Clinical Trials, Treatment & Research

Author: www.ncbi.nlm.nih.gov

Date Submitted: 03/30/2019 01:04 AM

Average star voting: 4 ⭐ ( 28095 reviews)

Summary:

Match with the search results: for the treatment of adults with active ankylosing spondylitis (AS) who have had an inadequate response or intolerance to one or more tumor ……. read more

2022 Ankylosing Spondylitis Clinical Trials, Treatment & Research

Related Posts

Leave a Reply

Your email address will not be published.